Valar Labs develops AI-powered diagnostics that analyze pathology slides to predict cancer treatment response. Their technology, exemplified by the Vesta platform for bladder cancer, aims to reduce uncertainty in treatment decisions and personalize care for patients. The company collaborates with healthcare providers and pharmaceutical companies to advance precision oncology.